Kathryn Haskins
Concepts (395)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diabetes Mellitus, Type 1 | 79 | 2025 | 3618 | 5.050 |
Why?
| Autoantigens | 34 | 2025 | 416 | 4.790 |
Why?
| CD4-Positive T-Lymphocytes | 33 | 2025 | 1046 | 4.670 |
Why?
| Mice, Inbred NOD | 69 | 2024 | 582 | 3.450 |
Why?
| Islets of Langerhans | 45 | 2025 | 790 | 3.330 |
Why?
| Chromogranin A | 9 | 2024 | 42 | 3.210 |
Why?
| T-Lymphocytes | 53 | 2025 | 1922 | 2.730 |
Why?
| Insulin | 19 | 2025 | 2318 | 2.110 |
Why?
| Epitopes, T-Lymphocyte | 11 | 2025 | 185 | 2.090 |
Why?
| Receptors, Antigen, T-Cell | 28 | 2021 | 701 | 2.050 |
Why?
| Islet Amyloid Polypeptide | 5 | 2018 | 46 | 1.990 |
Why?
| Peptides | 17 | 2024 | 909 | 1.880 |
Why?
| Diabetes Mellitus, Experimental | 15 | 2020 | 174 | 1.660 |
Why?
| Insulin-Secreting Cells | 9 | 2024 | 365 | 1.570 |
Why?
| Autoimmunity | 15 | 2022 | 860 | 1.570 |
Why?
| Peptide Fragments | 12 | 2024 | 685 | 1.460 |
Why?
| C-Peptide | 6 | 2025 | 163 | 1.440 |
Why?
| Mice | 94 | 2024 | 16579 | 1.270 |
Why?
| Clone Cells | 30 | 2018 | 254 | 1.220 |
Why?
| T-Lymphocytes, Regulatory | 5 | 2021 | 374 | 1.200 |
Why?
| Animals | 103 | 2024 | 34501 | 1.020 |
Why?
| Epitopes | 13 | 2024 | 466 | 1.000 |
Why?
| CD40 Antigens | 4 | 2012 | 88 | 0.900 |
Why?
| Antigen-Presenting Cells | 8 | 2014 | 150 | 0.860 |
Why?
| Islets of Langerhans Transplantation | 6 | 2022 | 59 | 0.850 |
Why?
| T-Lymphocytes, Helper-Inducer | 3 | 2019 | 136 | 0.830 |
Why?
| Adoptive Transfer | 16 | 2015 | 216 | 0.800 |
Why?
| Lymphocyte Activation | 16 | 2020 | 1098 | 0.780 |
Why?
| Mice, SCID | 15 | 2018 | 345 | 0.710 |
Why?
| Th1 Cells | 5 | 2009 | 136 | 0.700 |
Why?
| Nanoparticles | 3 | 2022 | 368 | 0.650 |
Why?
| Graft Survival | 1 | 2022 | 503 | 0.630 |
Why?
| CD4 Antigens | 5 | 2013 | 137 | 0.620 |
Why?
| Cells, Cultured | 13 | 2020 | 4008 | 0.600 |
Why?
| Mice, Transgenic | 20 | 2021 | 2069 | 0.570 |
Why?
| Pancreas | 6 | 2013 | 307 | 0.570 |
Why?
| Mice, Inbred BALB C | 18 | 2016 | 1229 | 0.570 |
Why?
| Recombinant Fusion Proteins | 3 | 2019 | 632 | 0.560 |
Why?
| Recombination, Genetic | 1 | 2018 | 188 | 0.560 |
Why?
| CD8-Positive T-Lymphocytes | 8 | 2025 | 840 | 0.550 |
Why?
| Histocompatibility Antigens Class II | 6 | 2013 | 359 | 0.530 |
Why?
| Macrophages | 6 | 2009 | 1463 | 0.520 |
Why?
| Immunotherapy | 1 | 2019 | 585 | 0.460 |
Why?
| CD40 Ligand | 2 | 2012 | 38 | 0.460 |
Why?
| Receptors, Antigen, T-Cell, alpha-beta | 9 | 2012 | 334 | 0.460 |
Why?
| Autoimmune Diseases | 7 | 2018 | 423 | 0.460 |
Why?
| Antigen Presentation | 3 | 2021 | 204 | 0.440 |
Why?
| Immune Tolerance | 5 | 2021 | 345 | 0.430 |
Why?
| Prediabetic State | 3 | 2013 | 245 | 0.430 |
Why?
| Histocompatibility Antigens | 3 | 2011 | 107 | 0.420 |
Why?
| Th2 Cells | 2 | 2007 | 167 | 0.420 |
Why?
| Mice, Knockout | 8 | 2021 | 2752 | 0.390 |
Why?
| Spleen | 11 | 2013 | 513 | 0.390 |
Why?
| Tumor Necrosis Factor-alpha | 3 | 2007 | 1190 | 0.380 |
Why?
| HLA-A2 Antigen | 2 | 2025 | 47 | 0.370 |
Why?
| Oxidative Stress | 4 | 2007 | 1188 | 0.360 |
Why?
| Histocompatibility Antigens Class I | 1 | 2012 | 195 | 0.350 |
Why?
| Flow Cytometry | 8 | 2015 | 1141 | 0.340 |
Why?
| Antigens, CD | 3 | 2008 | 479 | 0.340 |
Why?
| Macrophage Activation | 2 | 2007 | 186 | 0.330 |
Why?
| Specific Pathogen-Free Organisms | 3 | 2018 | 60 | 0.330 |
Why?
| Amino Acid Sequence | 8 | 2016 | 2041 | 0.310 |
Why?
| Diabetes Mellitus | 5 | 2014 | 1001 | 0.310 |
Why?
| Mass Spectrometry | 4 | 2023 | 660 | 0.310 |
Why?
| Cytokines | 9 | 2009 | 1985 | 0.300 |
Why?
| Interferon-gamma | 8 | 2020 | 761 | 0.300 |
Why?
| Receptors, CCR8 | 1 | 2007 | 2 | 0.290 |
Why?
| Chemokine CCL1 | 1 | 2007 | 2 | 0.290 |
Why?
| Autoantibodies | 6 | 2025 | 1463 | 0.280 |
Why?
| HLA-DQ Antigens | 3 | 2021 | 179 | 0.270 |
Why?
| Major Histocompatibility Complex | 10 | 2006 | 229 | 0.270 |
Why?
| Transforming Growth Factor beta | 1 | 2009 | 448 | 0.260 |
Why?
| Cell Line | 13 | 2013 | 2731 | 0.250 |
Why?
| Humans | 39 | 2025 | 128524 | 0.230 |
Why?
| T-Lymphocyte Subsets | 4 | 2003 | 410 | 0.220 |
Why?
| Thymus Gland | 5 | 2015 | 309 | 0.220 |
Why?
| Disease Models, Animal | 3 | 2019 | 3943 | 0.220 |
Why?
| Tyrosine | 2 | 2005 | 216 | 0.220 |
Why?
| Antibodies, Monoclonal | 12 | 2008 | 1355 | 0.220 |
Why?
| Female | 32 | 2025 | 68127 | 0.200 |
Why?
| Transglutaminases | 2 | 2013 | 153 | 0.200 |
Why?
| Regeneration | 1 | 2004 | 175 | 0.190 |
Why?
| Cell Movement | 4 | 2014 | 937 | 0.190 |
Why?
| CD11c Antigen | 2 | 2019 | 41 | 0.190 |
Why?
| Metalloporphyrins | 1 | 2002 | 101 | 0.190 |
Why?
| Polymorphism, Genetic | 1 | 2004 | 639 | 0.180 |
Why?
| B-Lymphocytes | 3 | 2015 | 820 | 0.180 |
Why?
| Crosses, Genetic | 3 | 2018 | 141 | 0.170 |
Why?
| Molecular Sequence Data | 4 | 2016 | 2818 | 0.170 |
Why?
| Antigens, Surface | 2 | 2000 | 150 | 0.170 |
Why?
| Transgenes | 1 | 2001 | 177 | 0.170 |
Why?
| Gene Products, gag | 1 | 2020 | 36 | 0.170 |
Why?
| Antigens, Differentiation | 1 | 2000 | 82 | 0.170 |
Why?
| Glutamate Decarboxylase | 5 | 2008 | 168 | 0.170 |
Why?
| Endogenous Retroviruses | 1 | 2020 | 35 | 0.160 |
Why?
| HLA-DRB1 Chains | 1 | 2020 | 108 | 0.160 |
Why?
| Cell Proliferation | 3 | 2019 | 2335 | 0.160 |
Why?
| Insulinoma | 2 | 2002 | 30 | 0.160 |
Why?
| Mice, Inbred Strains | 9 | 1998 | 402 | 0.160 |
Why?
| Recurrence | 1 | 2022 | 1001 | 0.150 |
Why?
| Immunoconjugates | 1 | 2000 | 101 | 0.150 |
Why?
| Cytoplasmic Granules | 3 | 2000 | 78 | 0.150 |
Why?
| Celiac Disease | 1 | 2021 | 287 | 0.150 |
Why?
| Lymphoid Tissue | 1 | 2018 | 68 | 0.150 |
Why?
| Forkhead Transcription Factors | 1 | 2019 | 179 | 0.150 |
Why?
| Animals, Genetically Modified | 1 | 2019 | 232 | 0.150 |
Why?
| Exocytosis | 1 | 2018 | 86 | 0.150 |
Why?
| Immune System | 1 | 2019 | 177 | 0.140 |
Why?
| Chromatography, Gel | 2 | 2012 | 127 | 0.140 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2012 | 2430 | 0.140 |
Why?
| Mice, Inbred C57BL | 6 | 2015 | 5257 | 0.140 |
Why?
| Cell Differentiation | 4 | 2020 | 1883 | 0.140 |
Why?
| Leukocytes | 1 | 1998 | 303 | 0.140 |
Why?
| Cell Division | 4 | 2004 | 779 | 0.130 |
Why?
| Cytotoxicity, Immunologic | 3 | 2002 | 218 | 0.130 |
Why?
| Enzyme-Linked Immunosorbent Assay | 3 | 2009 | 814 | 0.130 |
Why?
| Male | 21 | 2025 | 62883 | 0.130 |
Why?
| Diabetic Angiopathies | 2 | 2011 | 263 | 0.120 |
Why?
| Hybridomas | 11 | 2009 | 234 | 0.120 |
Why?
| Biocompatible Materials | 2 | 2012 | 395 | 0.120 |
Why?
| Microsatellite Repeats | 1 | 2015 | 161 | 0.120 |
Why?
| Antigens, Differentiation, T-Lymphocyte | 2 | 2007 | 87 | 0.120 |
Why?
| Disease Progression | 3 | 2019 | 2603 | 0.120 |
Why?
| Serine Endopeptidases | 1 | 2015 | 117 | 0.120 |
Why?
| CTLA-4 Antigen | 2 | 2008 | 88 | 0.120 |
Why?
| Antigens, Neoplasm | 2 | 1994 | 310 | 0.110 |
Why?
| Nitric Oxide | 3 | 2007 | 886 | 0.110 |
Why?
| Dendritic Cells | 2 | 2012 | 477 | 0.110 |
Why?
| Histocompatibility Testing | 1 | 2013 | 120 | 0.110 |
Why?
| Insulin, Regular, Human | 2 | 2024 | 42 | 0.110 |
Why?
| Signal Transduction | 5 | 2012 | 4829 | 0.110 |
Why?
| Microscopy, Fluorescence | 2 | 2012 | 402 | 0.110 |
Why?
| Primary Cell Culture | 1 | 2013 | 159 | 0.100 |
Why?
| Citrulline | 1 | 2013 | 43 | 0.100 |
Why?
| Proteomics | 2 | 2022 | 1004 | 0.100 |
Why?
| Fibrinogen | 1 | 2013 | 158 | 0.100 |
Why?
| Amino Acid Motifs | 2 | 2010 | 209 | 0.100 |
Why?
| T-Cell Antigen Receptor Specificity | 3 | 2012 | 51 | 0.100 |
Why?
| Interleukin-2 | 4 | 2000 | 430 | 0.100 |
Why?
| Lymph Nodes | 2 | 2013 | 467 | 0.090 |
Why?
| Transduction, Genetic | 1 | 2012 | 128 | 0.090 |
Why?
| Arthritis, Experimental | 1 | 2013 | 128 | 0.090 |
Why?
| Alleles | 2 | 2025 | 845 | 0.090 |
Why?
| Child | 7 | 2025 | 20721 | 0.090 |
Why?
| Antigens | 2 | 2024 | 352 | 0.090 |
Why?
| Transforming Growth Factor beta1 | 2 | 2012 | 155 | 0.090 |
Why?
| Lymphocyte Transfusion | 3 | 2005 | 20 | 0.090 |
Why?
| Complementarity Determining Regions | 2 | 2012 | 49 | 0.090 |
Why?
| Immunodominant Epitopes | 2 | 2009 | 28 | 0.090 |
Why?
| Carotid Artery Diseases | 1 | 2011 | 65 | 0.090 |
Why?
| RNA, Messenger | 4 | 2005 | 2674 | 0.090 |
Why?
| Ovalbumin | 3 | 2021 | 177 | 0.080 |
Why?
| HLA-A Antigens | 1 | 2010 | 53 | 0.080 |
Why?
| Endothelium, Vascular | 2 | 2007 | 871 | 0.080 |
Why?
| Up-Regulation | 2 | 2013 | 826 | 0.080 |
Why?
| Receptors, Interleukin-2 | 2 | 2000 | 65 | 0.080 |
Why?
| Adolescent | 5 | 2025 | 20213 | 0.080 |
Why?
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 3 | 2006 | 25 | 0.080 |
Why?
| Receptors, Transforming Growth Factor beta | 1 | 2009 | 52 | 0.080 |
Why?
| Chromosome Mapping | 2 | 2004 | 505 | 0.080 |
Why?
| CD28 Antigens | 1 | 2008 | 48 | 0.080 |
Why?
| Receptor-Like Protein Tyrosine Phosphatases, Class 8 | 1 | 2008 | 62 | 0.080 |
Why?
| Gene Expression | 1 | 2013 | 1462 | 0.080 |
Why?
| Disease Susceptibility | 2 | 2004 | 334 | 0.070 |
Why?
| Inducible T-Cell Co-Stimulator Protein | 1 | 2007 | 9 | 0.070 |
Why?
| Polyethylene Glycols | 3 | 2012 | 597 | 0.070 |
Why?
| Organ Specificity | 1 | 2008 | 291 | 0.070 |
Why?
| Isoenzymes | 2 | 2006 | 304 | 0.070 |
Why?
| CD11b Antigen | 1 | 2007 | 59 | 0.070 |
Why?
| Macrophages, Peritoneal | 1 | 2007 | 90 | 0.070 |
Why?
| Chemotaxis | 1 | 2007 | 130 | 0.070 |
Why?
| Receptors, Tumor Necrosis Factor | 1 | 2007 | 162 | 0.070 |
Why?
| Biomarkers | 1 | 2018 | 3881 | 0.070 |
Why?
| Adult | 6 | 2025 | 35315 | 0.070 |
Why?
| Hydrogels | 3 | 2012 | 636 | 0.070 |
Why?
| Pancreatic Neoplasms | 1 | 1994 | 878 | 0.060 |
Why?
| Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 2 | 2004 | 21 | 0.060 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2008 | 937 | 0.060 |
Why?
| Mice, Mutant Strains | 3 | 1991 | 292 | 0.060 |
Why?
| Young Adult | 4 | 2025 | 12320 | 0.060 |
Why?
| Prostaglandins | 1 | 2005 | 84 | 0.060 |
Why?
| Enzyme-Linked Immunospot Assay | 1 | 2025 | 35 | 0.060 |
Why?
| Genes, T-Cell Receptor | 1 | 2005 | 9 | 0.060 |
Why?
| Receptors, Chemokine | 1 | 2005 | 45 | 0.060 |
Why?
| Receptors, Cytokine | 1 | 2005 | 35 | 0.060 |
Why?
| Species Specificity | 4 | 2006 | 567 | 0.060 |
Why?
| Immunoglobulin Allotypes | 1 | 1984 | 9 | 0.060 |
Why?
| Cell Adhesion Molecules | 1 | 2005 | 172 | 0.060 |
Why?
| Lymphocyte Depletion | 3 | 2000 | 129 | 0.060 |
Why?
| Mice, Congenic | 1 | 2004 | 22 | 0.060 |
Why?
| Rats | 5 | 2000 | 5168 | 0.060 |
Why?
| Proinsulin | 1 | 2024 | 52 | 0.060 |
Why?
| Arthritis, Rheumatoid | 1 | 2013 | 1108 | 0.050 |
Why?
| Molecular Mimicry | 1 | 2003 | 37 | 0.050 |
Why?
| Chemokines | 1 | 2005 | 221 | 0.050 |
Why?
| Aging | 4 | 2005 | 1770 | 0.050 |
Why?
| Electrophoresis, Polyacrylamide Gel | 2 | 2000 | 323 | 0.050 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 756 | 0.050 |
Why?
| Aspartic Acid | 1 | 2023 | 79 | 0.050 |
Why?
| Genes, RAG-1 | 1 | 2003 | 11 | 0.050 |
Why?
| Cathepsin D | 1 | 2022 | 17 | 0.050 |
Why?
| DNA Primers | 1 | 2004 | 510 | 0.050 |
Why?
| Immunoglobulin G | 2 | 1997 | 837 | 0.050 |
Why?
| Cyclic AMP Response Element-Binding Protein | 1 | 2003 | 141 | 0.050 |
Why?
| Extracellular Matrix | 1 | 2007 | 497 | 0.050 |
Why?
| Solubility | 2 | 2000 | 229 | 0.050 |
Why?
| Antibody Specificity | 5 | 1996 | 182 | 0.050 |
Why?
| Respiratory Burst | 1 | 2002 | 15 | 0.050 |
Why?
| Glucose | 3 | 2007 | 983 | 0.050 |
Why?
| Vasodilation | 1 | 2005 | 478 | 0.050 |
Why?
| Molecular Weight | 5 | 2006 | 331 | 0.050 |
Why?
| RNA, Small Interfering | 1 | 2004 | 571 | 0.050 |
Why?
| Cytoprotection | 1 | 2021 | 50 | 0.050 |
Why?
| In Vitro Techniques | 1 | 2023 | 1043 | 0.050 |
Why?
| Superoxide Dismutase | 1 | 2003 | 322 | 0.050 |
Why?
| Leukemia L1210 | 1 | 2001 | 7 | 0.050 |
Why?
| K562 Cells | 1 | 2021 | 82 | 0.050 |
Why?
| Phosphotyrosine | 1 | 2001 | 36 | 0.050 |
Why?
| Interphase | 1 | 2001 | 31 | 0.050 |
Why?
| L-Selectin | 1 | 2001 | 24 | 0.050 |
Why?
| Perforin | 1 | 2001 | 19 | 0.050 |
Why?
| Pore Forming Cytotoxic Proteins | 1 | 2001 | 16 | 0.050 |
Why?
| Gene Rearrangement | 1 | 2002 | 145 | 0.040 |
Why?
| Antigens, Viral | 1 | 2021 | 174 | 0.040 |
Why?
| Injections, Intravenous | 1 | 2001 | 193 | 0.040 |
Why?
| fas Receptor | 1 | 2001 | 95 | 0.040 |
Why?
| Integrins | 1 | 2001 | 92 | 0.040 |
Why?
| Chromatography, Ion Exchange | 1 | 2000 | 52 | 0.040 |
Why?
| Detergents | 1 | 2000 | 45 | 0.040 |
Why?
| Heat-Shock Proteins | 2 | 2001 | 131 | 0.040 |
Why?
| Hemocyanins | 1 | 2000 | 61 | 0.040 |
Why?
| Abatacept | 1 | 2000 | 47 | 0.040 |
Why?
| Cross Reactions | 1 | 2020 | 127 | 0.040 |
Why?
| Cell Lineage | 1 | 2021 | 333 | 0.040 |
Why?
| Mice, Inbred DBA | 3 | 2013 | 182 | 0.040 |
Why?
| Glycoproteins | 1 | 2021 | 337 | 0.040 |
Why?
| Maternal-Fetal Exchange | 2 | 1997 | 161 | 0.040 |
Why?
| Immunophenotyping | 1 | 2001 | 312 | 0.040 |
Why?
| Promoter Regions, Genetic | 1 | 2004 | 1199 | 0.040 |
Why?
| Clonal Anergy | 1 | 1999 | 51 | 0.040 |
Why?
| Cell-Derived Microparticles | 1 | 2020 | 61 | 0.040 |
Why?
| Viral Proteins | 1 | 2021 | 321 | 0.040 |
Why?
| Gene Expression Regulation | 2 | 2012 | 2506 | 0.040 |
Why?
| Macromolecular Substances | 3 | 1991 | 211 | 0.040 |
Why?
| Pancreatitis | 1 | 2000 | 128 | 0.040 |
Why?
| Transfection | 1 | 2001 | 895 | 0.040 |
Why?
| Interleukin-13 | 1 | 1999 | 145 | 0.040 |
Why?
| Membrane Glycoproteins | 1 | 2001 | 466 | 0.040 |
Why?
| Intracellular Membranes | 1 | 1998 | 82 | 0.040 |
Why?
| Lipopolysaccharides | 1 | 2002 | 856 | 0.040 |
Why?
| Muramidase | 1 | 1998 | 75 | 0.040 |
Why?
| Lupus Erythematosus, Systemic | 1 | 2001 | 249 | 0.040 |
Why?
| Immunity, Maternally-Acquired | 1 | 1997 | 18 | 0.040 |
Why?
| NF-kappa B | 1 | 2002 | 651 | 0.040 |
Why?
| Antibodies | 1 | 2000 | 391 | 0.040 |
Why?
| Rats, Inbred Strains | 2 | 1990 | 356 | 0.040 |
Why?
| Materials Testing | 2 | 2012 | 346 | 0.040 |
Why?
| Obesity | 1 | 1990 | 2860 | 0.040 |
Why?
| Multigene Family | 1 | 1997 | 198 | 0.030 |
Why?
| Animals, Newborn | 3 | 2005 | 805 | 0.030 |
Why?
| Tumor Cells, Cultured | 2 | 2000 | 927 | 0.030 |
Why?
| Cloning, Molecular | 3 | 2003 | 522 | 0.030 |
Why?
| Glutathione | 1 | 1998 | 334 | 0.030 |
Why?
| Cell Membrane | 1 | 2000 | 722 | 0.030 |
Why?
| Phosphorylation | 1 | 2001 | 1681 | 0.030 |
Why?
| Leukocytes, Mononuclear | 1 | 2019 | 538 | 0.030 |
Why?
| NADPH Oxidases | 2 | 2007 | 108 | 0.030 |
Why?
| Insulin Antibodies | 1 | 1996 | 105 | 0.030 |
Why?
| T-Lymphocytes, Cytotoxic | 1 | 1996 | 168 | 0.030 |
Why?
| DNA-Binding Proteins | 1 | 2003 | 1415 | 0.030 |
Why?
| Immunohistochemistry | 2 | 2000 | 1669 | 0.030 |
Why?
| Predictive Value of Tests | 1 | 2001 | 1936 | 0.030 |
Why?
| Immunization | 2 | 1996 | 411 | 0.030 |
Why?
| Thymocytes | 1 | 2015 | 32 | 0.030 |
Why?
| Stromal Cells | 1 | 2015 | 105 | 0.030 |
Why?
| Mice, Inbred AKR | 4 | 1997 | 34 | 0.030 |
Why?
| Genetic Linkage | 1 | 1995 | 299 | 0.030 |
Why?
| Centrifugation, Density Gradient | 1 | 1994 | 39 | 0.030 |
Why?
| Culture Techniques | 1 | 1994 | 81 | 0.030 |
Why?
| Cell Fractionation | 1 | 1994 | 56 | 0.030 |
Why?
| Binding Sites, Antibody | 2 | 1984 | 42 | 0.030 |
Why?
| Journal Impact Factor | 1 | 2014 | 31 | 0.030 |
Why?
| Antigen-Antibody Reactions | 2 | 1984 | 51 | 0.030 |
Why?
| Genetic Markers | 1 | 1995 | 339 | 0.030 |
Why?
| Membrane Proteins | 1 | 2000 | 1108 | 0.030 |
Why?
| Middle Aged | 2 | 2025 | 30893 | 0.030 |
Why?
| Gene Rearrangement, T-Lymphocyte | 1 | 1993 | 15 | 0.030 |
Why?
| Rats, Inbred BB | 1 | 1993 | 5 | 0.030 |
Why?
| Cell Survival | 2 | 2007 | 1077 | 0.030 |
Why?
| Immunosuppressive Agents | 2 | 2012 | 686 | 0.030 |
Why?
| Collagen Type II | 1 | 2013 | 47 | 0.030 |
Why?
| CD8 Antigens | 1 | 1992 | 75 | 0.030 |
Why?
| Trinitrobenzenes | 1 | 1992 | 14 | 0.030 |
Why?
| Adenoma, Islet Cell | 1 | 1992 | 10 | 0.030 |
Why?
| Hybrid Cells | 1 | 1992 | 50 | 0.030 |
Why?
| Haptens | 1 | 1992 | 22 | 0.030 |
Why?
| Immunity, Innate | 1 | 1998 | 803 | 0.020 |
Why?
| Publishing | 1 | 2014 | 141 | 0.020 |
Why?
| Polymerase Chain Reaction | 2 | 1993 | 1019 | 0.020 |
Why?
| Immunoglobulin Idiotypes | 4 | 1983 | 27 | 0.020 |
Why?
| Kinetics | 1 | 1995 | 1616 | 0.020 |
Why?
| Receptors, Antigen, B-Cell | 1 | 1992 | 126 | 0.020 |
Why?
| Coculture Techniques | 1 | 2012 | 225 | 0.020 |
Why?
| Periodicals as Topic | 1 | 2014 | 206 | 0.020 |
Why?
| Base Sequence | 2 | 1993 | 2134 | 0.020 |
Why?
| Neointima | 1 | 2011 | 15 | 0.020 |
Why?
| Germ-Line Mutation | 1 | 2012 | 138 | 0.020 |
Why?
| Mice, Nude | 1 | 1993 | 682 | 0.020 |
Why?
| Colorado | 1 | 2001 | 4392 | 0.020 |
Why?
| Mice, Inbred CBA | 1 | 1990 | 52 | 0.020 |
Why?
| Collagen | 1 | 2013 | 429 | 0.020 |
Why?
| CD4 Lymphocyte Count | 1 | 2011 | 265 | 0.020 |
Why?
| Interleukin-10 | 1 | 2012 | 299 | 0.020 |
Why?
| Age Factors | 2 | 1995 | 3117 | 0.020 |
Why?
| Sex Factors | 1 | 1995 | 1949 | 0.020 |
Why?
| Genes, MHC Class II | 1 | 1989 | 72 | 0.020 |
Why?
| Leukemia, Lymphoid | 2 | 2006 | 27 | 0.020 |
Why?
| Epitope Mapping | 1 | 2009 | 57 | 0.020 |
Why?
| Pituitary Gland | 1 | 1989 | 148 | 0.020 |
Why?
| Trypsin | 2 | 2006 | 74 | 0.020 |
Why?
| Lymphokines | 1 | 1988 | 115 | 0.020 |
Why?
| Conserved Sequence | 1 | 2009 | 228 | 0.020 |
Why?
| Tissue Distribution | 2 | 1985 | 290 | 0.020 |
Why?
| Cell Separation | 1 | 1988 | 313 | 0.020 |
Why?
| Stem Cell Transplantation | 1 | 2008 | 164 | 0.020 |
Why?
| Kidney Transplantation | 1 | 1992 | 604 | 0.020 |
Why?
| Salivary Glands | 1 | 2006 | 29 | 0.020 |
Why?
| Mucoproteins | 1 | 2005 | 10 | 0.020 |
Why?
| Receptors, Thromboxane A2, Prostaglandin H2 | 1 | 2005 | 3 | 0.020 |
Why?
| Acetophenones | 1 | 2005 | 13 | 0.020 |
Why?
| Onium Compounds | 1 | 2005 | 11 | 0.020 |
Why?
| Hydrogen Peroxide | 1 | 2007 | 308 | 0.020 |
Why?
| Prostaglandin-Endoperoxide Synthases | 1 | 2005 | 73 | 0.020 |
Why?
| Cell Adhesion | 1 | 2007 | 444 | 0.020 |
Why?
| Cyclooxygenase Inhibitors | 1 | 2005 | 80 | 0.020 |
Why?
| Drug Compounding | 1 | 2005 | 95 | 0.020 |
Why?
| Acetylcholine | 1 | 2005 | 183 | 0.010 |
Why?
| History, 20th Century | 1 | 2006 | 291 | 0.010 |
Why?
| Precipitin Tests | 1 | 1984 | 93 | 0.010 |
Why?
| Genetic Predisposition to Disease | 1 | 1993 | 2266 | 0.010 |
Why?
| Isoelectric Point | 1 | 1984 | 23 | 0.010 |
Why?
| Disulfides | 1 | 1984 | 96 | 0.010 |
Why?
| Genes, T-Cell Receptor alpha | 1 | 2003 | 12 | 0.010 |
Why?
| Genes, T-Cell Receptor beta | 1 | 2003 | 21 | 0.010 |
Why?
| Chemical Precipitation | 1 | 1983 | 37 | 0.010 |
Why?
| Aorta | 1 | 2005 | 407 | 0.010 |
Why?
| Protein Binding | 1 | 2009 | 2097 | 0.010 |
Why?
| DNA, Complementary | 1 | 2003 | 267 | 0.010 |
Why?
| Peptide Library | 1 | 2002 | 85 | 0.010 |
Why?
| Receptors, Immunologic | 1 | 1983 | 209 | 0.010 |
Why?
| Inflammation | 2 | 2006 | 2664 | 0.010 |
Why?
| Oxidation-Reduction | 1 | 2005 | 1001 | 0.010 |
Why?
| Homeostasis | 1 | 2005 | 605 | 0.010 |
Why?
| Haplotypes | 1 | 2003 | 471 | 0.010 |
Why?
| Immunoenzyme Techniques | 1 | 2001 | 206 | 0.010 |
Why?
| Time Factors | 1 | 2012 | 6503 | 0.010 |
Why?
| Growth Inhibitors | 1 | 2000 | 43 | 0.010 |
Why?
| Ligands | 1 | 2002 | 614 | 0.010 |
Why?
| Injections, Intraperitoneal | 1 | 2000 | 105 | 0.010 |
Why?
| Blood Glucose | 3 | 1999 | 2092 | 0.010 |
Why?
| Nitric Oxide Synthase Type II | 1 | 2000 | 167 | 0.010 |
Why?
| Pancreatic Ducts | 1 | 2000 | 80 | 0.010 |
Why?
| Nitric Oxide Synthase | 1 | 2000 | 232 | 0.010 |
Why?
| Complement C5 | 1 | 1999 | 76 | 0.010 |
Why?
| Cell Transplantation | 1 | 1999 | 35 | 0.010 |
Why?
| Epithelium | 1 | 2000 | 306 | 0.010 |
Why?
| H-2 Antigens | 1 | 1999 | 114 | 0.010 |
Why?
| Models, Immunological | 1 | 1999 | 94 | 0.010 |
Why?
| Rats, Wistar | 1 | 2000 | 398 | 0.010 |
Why?
| Interleukin-4 | 1 | 1999 | 213 | 0.010 |
Why?
| Conalbumin | 1 | 1997 | 3 | 0.010 |
Why?
| Apoptosis | 1 | 2007 | 2437 | 0.010 |
Why?
| Immune Sera | 1 | 1997 | 86 | 0.010 |
Why?
| Superantigens | 1 | 1997 | 70 | 0.010 |
Why?
| Enterotoxins | 1 | 1997 | 89 | 0.010 |
Why?
| Immunoglobulin E | 1 | 1999 | 329 | 0.010 |
Why?
| Injections, Subcutaneous | 1 | 1997 | 145 | 0.010 |
Why?
| Genes, Immunoglobulin | 1 | 1996 | 28 | 0.010 |
Why?
| Spodoptera | 1 | 1996 | 37 | 0.010 |
Why?
| Enzyme Inhibitors | 1 | 2000 | 811 | 0.010 |
Why?
| Baculoviridae | 1 | 1996 | 44 | 0.010 |
Why?
| Homeodomain Proteins | 1 | 1999 | 487 | 0.010 |
Why?
| Antibody Formation | 1 | 1996 | 287 | 0.010 |
Why?
| Pregnancy | 2 | 1997 | 6297 | 0.010 |
Why?
| Submandibular Gland | 1 | 1993 | 19 | 0.010 |
Why?
| Staphylococcus aureus | 1 | 1997 | 425 | 0.010 |
Why?
| Oligodeoxyribonucleotides | 1 | 1993 | 138 | 0.010 |
Why?
| Globins | 1 | 1989 | 21 | 0.010 |
Why?
| Antigens, Ly | 1 | 1984 | 45 | 0.000 |
Why?
| Isoelectric Focusing | 1 | 1983 | 34 | 0.000 |
Why?
| Chickens | 1 | 1983 | 188 | 0.000 |
Why?
| Birds | 1 | 1983 | 74 | 0.000 |
Why?
| Immunologic Techniques | 1 | 1983 | 38 | 0.000 |
Why?
| Molecular Conformation | 1 | 1983 | 139 | 0.000 |
Why?
| DNA | 1 | 1989 | 1392 | 0.000 |
Why?
|
|
Haskins's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|